Replying to:
Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment
The Latin American Group of Osteosarcoma Treatment has just published in Cancer the results of a randomized trial, evaluation the addition of a metronomic maintenance for patients with a resectable, non metastatic osteosarcoma. The first author of the paper, Andreza A. Senerchia, is one of our MGHI member. Although, at last follow-up, EFS with MAP plus MC maintenance is not statistically superior to EFS with MAP alone in patients with high-grade, resectable OSTs of the extremities, one (...)
